FDA Approves Imcivree for Rare Genetic Obesity Disorders
The FDA has approved Imcivree™ (setmelanotide; Rhythm Pharmaceuticals) for chronic weight management in patients with obesity due to POMC, PCSK1, or LEPR deficiency.
Pigmentation Disorders
Single-Agent Chemical Peels for Melasma Treatment in Skin of Color
The efficacy and safety of single-agent chemical peels in patients with pigmented skin, was investigated via a systematic review and meta-analysis of the current literature.
Expert Roundtable: Racial Disparities in Dermatology Care
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.
Pulse-Dye Laser Without General Anesthesia is Well Tolerated by Infants and Toddlers
A novel study characterizes short-term pain and documents tolerance of office-based Pulse-dye laser (PDL) treatments for port wine birthmark in an age group that cannot verbalize their treatment experience.
Skin of Color Disproportionately Affected by Cutaneous Disorders
The racial and ethnic distribution of common dermatologic disorders seen at a US tertiary care center are characterized.
Management Strategies for Depigmented Skin
Strategies for the treatment of depigmented skin are reviewed in this study.
Green Tea, Coffee Consumption May Alleviate, Prevent Skin Photoaging
How much of an influence does the consumption of polyphenols have on the suppression of pigmented spots? A considerable influence, a study finds.
Tixel-Induced Rapamycin Delivery After Pulsed Dye Laser for Port Wine Stain
The use of the drug delivery system combined with topical rapamycin improves the results of pulsed dye laser (PDL) treatment for port wine stains and can reduce the total number of necessary PDL sessions, with no remarkable adverse events.
Study Finds Multiple New Disease Associations With Vitiligo
Clinicians should be aware of comorbidities that can occur with vitiligo and how these can vary by demographic group.
Combination Melasma Treatment With Fewer Active Components May Be Effective
A triple combination melanoma treatment containing active ingredients with lesser concentrations than proposed, and with the addition of 2% salicylic acid, may be promising.
-
Loading...
-
Loading...
Next post in General Dermatology
